Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CELU is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
8 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 4
39 filers reported a long position in CELU for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| C V STARR & CO INC | $1.6M | 764.1K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $371.4K | 621.1K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $100K | 167.2K | -12.5% |
| CITADEL ADVISORS LLC | $59.2K | 99.1K | New |
| VANGUARD FIDUCIARY TRUST CO | $47.8K | 79.9K | Unchanged |
| BlackRock, Inc. | $45.7K | 76.4K | -40.1% |
| STATE STREET CORP | $34.6K | 57.8K | Unchanged |
| HRT FINANCIAL LP | $33K | 56.6K | +342.7% |
| NORTHERN TRUST CORP | $26.4K | 44.2K | Unchanged |
| Biltmore Family Office, LLC | $20.9K | 35K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.